Burke T G, Pritsos C A, Sartorelli A C, Tritton T R
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510.
Cancer Biochem Biophys. 1987 Sep;9(3):245-55.
The effects of anthracyclines on the stimulation of oxygen consumption in the presence of HL-60 cell sonicates, beef heart mitochondria and NADPH cytochrome c reductase were determined as a measure of oxygen radical production. Drug-induced oxygen radical formation in each of these systems was modulated by structural changes in the aglycone as well as in the amino sugar portion of the anthracycline molecule. Cytotoxic potency was not correlated with anthracycline-induced oxygen consumption, suggesting that net oxygen radical production was not the primary factor in tumor cell killing by anthracyclines. In contrast, available data on anthracycline cardiotoxicity appeared to correlate with the drug-induced stimulation of oxygen consumption by beef heart mitochondria, providing support for the premise that drug-induced oxygen radicals formed in the presence of mitochondrial flavoproteins are involved in the adverse effects of anthracyclines on the heart. Cyanomorpholinoadriamycin, an analogue which is 100 to 1000 times more potent than adriamycin (doxorubicin) as an antineoplastic agent, has been shown here and elsewhere to be equivalent to adriamycin in stimulating oxygen radical production by beef heart mitochondria and to produce similar cardiotoxicity at equimolar concentrations. Thus, it appears possible to separate the favorable antitumor activity of adriamycin from its unwanted cardiotoxicity by structural changes such as substitution of the antibiotic by a cyanomorpholino moiety.
测定了蒽环类药物在HL - 60细胞超声提取物、牛心线粒体和NADPH细胞色素c还原酶存在的情况下对氧消耗刺激的影响,以此作为氧自由基产生的一种度量。在这些系统中,药物诱导的氧自由基形成受到蒽环类分子苷元以及氨基糖部分结构变化的调节。细胞毒性效力与蒽环类药物诱导的氧消耗不相关,这表明净氧自由基产生不是蒽环类药物杀死肿瘤细胞的主要因素。相反,关于蒽环类药物心脏毒性的现有数据似乎与药物诱导的牛心线粒体氧消耗刺激相关,这支持了以下前提:在存在线粒体黄素蛋白的情况下形成的药物诱导的氧自由基参与了蒽环类药物对心脏的不良反应。氰基吗啉代阿霉素是一种比阿霉素(多柔比星)作为抗肿瘤药物效力高100至1000倍的类似物,在此处及其他地方已表明,它在刺激牛心线粒体产生氧自由基方面与阿霉素相当,并且在等摩尔浓度下产生类似的心脏毒性。因此,似乎有可能通过结构变化,如用氰基吗啉代部分取代抗生素,将阿霉素有利的抗肿瘤活性与其不良的心脏毒性分开。